PERSTORP, Sweden - Perstorp is doubling the production capacity of its recently acquired Capa® caprolactone plant in Warrington, England. The groundwork for this investment is now complete and the expanded capacity will be operational in the first half of 2010. The new monomer capacity will be based on Perstorp’s proprietary technology.
The market for caprolactone and its derivatives is growing rapidly and Perstorp’s investment to double its production capacity of monomer, as well as increasing the capacity of polycaprolactone polyol, is a direct response to this growth.
“We are investing in our Capa caprolactones and predict a bright future for these products that complement our current portfolio of special polyols perfectly and give our customers an edge in spearheading the development of new products and applications,” said Mårten Olausson, Vice President BU Caprolactones.